EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes

The time trade-off (TTO) valuation technique is widely used to determine utility values of health outcomes to inform quality-adjusted life-year (QALY) calculations for use in economic evaluation. Protocols for implementing TTO vary in aspects such as the trade-off framework, iteration procedure and its administration model and method, training of respondents and interviewers, and quality control of data collection. The most widely studied and utilized TTO valuation protocols are the Measurement and Valuation of Health (MVH) protocol, the Paris protocol and the EuroQol Valuation Technology (EQ-VT) protocol, all developed by members of the EuroQol Group. The MVH protocol and its successor, the Paris protocol, were developed for valuation of EQ-5D-3L health states. Both protocols were designed for a trained interviewer to elicit preferences from a respondent using the conventional TTO framework with a fixed time horizon of 10 years and an iteration procedure combining bisection and titration. Developed for valuation of EQ-5D-5L health states, the EQ-VT protocol adopted a composite TTO framework and made use of computer technology to facilitate data collection. Training and monitoring of interviewers and respondents is a pivotal component of the EQ-VT protocol. Research is underway aiming to further improve the EuroQol protocols, which form an important basis for the current practice of health technology assessment in many countries.

[1]  P. Kind,et al.  EQ-5D-3L as a health measure of Brazilian adult population , 2015, Quality of Life Research.

[2]  Mark Oppe,et al.  Discrete choice modeling for the quantification of health states: the case of the EQ-5D. , 2010, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[3]  Peep F M Stalmeier,et al.  Inconsistencies in TTO and VAS Values for EQ-5D Health States , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.

[4]  P. Dolan,et al.  Time preference, duration and health state valuations. , 1995, Health economics.

[5]  P F Stalmeier,et al.  A FALLACY OF THE MULTIPLICATIVE QALY MODEL FOR LOW-QUALITY WEIGHTS IN STUDENTS AND PATIENTS JUDGING HYPOTHETICAL HEALTH STATES , 2001, International Journal of Technology Assessment in Health Care.

[6]  Angela Robinson,et al.  Exploring challenges to TTO utilities: valuing states worse than dead. , 2006, Health economics.

[7]  M. Johannesson,et al.  Standard gamble, time trade-off and rating scale: experimental results on the ranking properties of QALYs. , 1997, Journal of health economics.

[8]  R. Brooks.  EuroQol: the current state of play. , 1996, Health policy.

[9]  P. Ferreira,et al.  The valuation of the EQ-5D in Portugal , 2014, Quality of Life Research.

[10]  Michael Herdman,et al.  Development of the EQ-5D-Y: a child-friendly version of the EQ-5D , 2010, Quality of Life Research.

[11]  Mark Oppe,et al.  Introducing the composite time trade-off: a test of feasibility and face validity , 2013, The European Journal of Health Economics.

[12]  Peep F M Stalmeier,et al.  The gap effect: discontinuities of preferences around dead. , 2005, Health economics.

[13]  X. Badia,et al.  Inconsistent responses in three preference-elicitation methods for health states. , 1999, Social science & medicine.

[14]  N. Luo,et al.  Chinese time trade-off values for EQ-5D health states. , 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[15]  Stephen Joel Coons,et al.  US Valuation of the EQ-5D Health States: Development and Testing of the D1 Valuation Model , 2005, Medical care.

[16]  Nan Luo,et al.  The effects of lead time and visual aids in TTO valuation: a study of the EQ-VT framework , 2013, The European Journal of Health Economics.

[17]  A. Williams.  EuroQol : a new facility for the measurement of health-related quality of life , 1990 .

[18]  P. Dolan,et al.  Modelling valuations for health states: the effect of duration. , 1996, Health policy.

[19]  Gérard de Pouvourville,et al.  Valuing EQ-5D using Time Trade-Off in France , 2013, The European Journal of Health Economics.

[20]  Lee Bowman,et al.  Challenges to time trade-off utility assessment methods: when should you consider alternative approaches? , 2014, Expert review of pharmacoeconomics & outcomes research.

[21]  M. Trommald,et al.  Are QALYs based on time trade-off comparable?--A systematic review of TTO methodologies. , 2005, Health economics.

[22]  K C Cain,et al.  Measuring Preferences for Health States Worse than Death , 1994, Medical decision making : an international journal of the Society for Medical Decision Making.

[23]  Paul F. M. Krabbe,et al.  The development of new research methods for the valuation of EQ-5D-5L , 2013, The European Journal of Health Economics.

[24]  Paul Kind,et al.  South Korean time trade-off values for EQ-5D health states: modeling with observed values for 101 health states. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[25]  M Ryan,et al.  Eliciting public preferences for healthcare: a systematic review of techniques. , 2001, Health technology assessment.

[26]  Joseph S. Pliskin,et al.  Utility Functions for Life Years and Health Status , 1980, Oper. Res..

[27]  Mark Oppe,et al.  From a different angle: a novel approach to health valuation. , 2010, Social science & medicine.

[28]  Mark Oppe,et al.  One-to-one versus group setting for conducting computer-assisted TTO studies: findings from pilot studies in England and the Netherlands , 2013, The European Journal of Health Economics.

[29]  L. Lamers.  The Transformation of Utilities for Health States Worse Than Death: Consequences for the Estimation of EQ-5D Value Sets , 2007, Medical care.

[30]  A. Pickard,et al.  A median model for predicting United States population-based EQ-5D health state preferences. , 2010, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[31]  Mark Oppe,et al.  A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol. , 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[32]  L. Lenert,et al.  The Effect of Search Procedures on Utility Elicitations , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[33]  P. Dolan,et al.  Modeling valuations for EuroQol health states. , 1997, Medical care.

[34]  A. Kasuya.  EuroQol--a new facility for the measurement of health-related quality of life. , 1990, Health policy.

[35]  L. Longworth,et al.  An Empirical Study of Two Alternative Comparators for Use in Time Trade-Off Studies. , 2016, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[36]  Mark Oppe,et al.  EQ-5D Value Sets , 2007 .

[37]  N. Devlin,et al.  Time to tweak the TTO: results from a comparison of alternative specifications of the TTO , 2013, The European Journal of Health Economics.

[38]  G. Bonsel,et al.  Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) , 2011, Quality of Life Research.

[39]  C. Carswell.  Measuring and Valuing Health Benefits for Economic Valuation , 2007, PharmacoEconomics.

[40]  G W Torrance,et al.  A utility maximization model for evaluation of health care programs. , 1972, Health services research.

[41]  Mark Oppe,et al.  Valuation and Modeling of EQ-5D-5L Health States Using a Hybrid Approach , 2014, Medical care.

[42]  Aki Tsuchiya,et al.  A comparison of alternative variants of the lead and lag time TTO. , 2013, Health economics.

[43]  K. Stavem,et al.  Impact of Transformation of Negative Values and Regression Models on Differences Between the UK and US EQ-5D Time Trade-Off Value Sets , 2012, PharmacoEconomics.

[44]  A. Miners.  Estimating ‘Costs’ for Cost-Effectiveness Analysis , 2012, PharmacoEconomics.

[45]  Mark Oppe,et al.  Lead versus lag-time trade-off variants: does it make any difference? , 2013, The European Journal of Health Economics.

[46]  Mark Oppe,et al.  EQ-5D value sets : inventory, comparative review, and user guide , 2007 .